30 PEDs making the choice

UNIVERSITY

PEDs
Making the Choice and
Limiting the Risk


User Checklist
1.
2.
3.

4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.

Have you spent time maximizing all variables (training, nutrition,
sleep, stress management)?
Do you understand the short and long term risk of PED usage?
Do you understand how PEDs work mechanistically? Basic
endocrinology and compound choices?
Do you understand safety/risk criteria in compound selection?

Do you have access to quality product?
Any legal matters to consider?
Do you know safe and risk reduction administration/consumption
practice?
Do you understand esters and administration frequency?
Do you know how to handle estrogen and DHT side effects? Ancillary
compounds on hand?
Do you know the health and lab markers to monitor
before/during/after?
Will you blast/cruise or blast/PCT?
How and what do you need for PCT?
Do you know the support supplements/drugs needed for PED usage?
Can you afford all the above without limitations?
Do you have support from your social network in this?


Safer Usage Framework
1. Monitor lab work 8-12 weeks, blood pressure, blood glucose once
per week.
2. Use Reasonable dosages and escalate step-based to see out our
goals.
3. Utilize compounds approved at some point for human usage for
”less” risk
4. Testosterone as a starting point (males)
5. Minimize the use of 17aa oral AAS
6. Have planned cruise or off periods
7. Have supplement health strategies in place for heart, liver,
kidneys, brain, testes, pancreas and whole system.
8. Limit aromatase Inhibitors and SERMs unless absolutely needed to
see out our goals as we advance

9. Seek Pharm grade > Generic grade > Under ground Lab grade
10. Proper Injection and Sterilization Procedures


Dose Response Relationship and Goals
•
•
•

Use a step-based Approach as need to achieve you goals
and minimize risk.
Dosage and risk escalates only as needed.
Don’t start at the ceiling when you have easy progress to
make on less

Risk

Low T

TRT

Supra
Physiological T

Testosterone Dosage


PED Deployment
Anabolic Androgenic Steroids

Ancillary Compounds

Testosterone Based
Testosterone
Boldenone**
Halotestin*
Dianabol*

Estrogen and Fertility Management
Anastrozole*
Extremestane*
Nolvadex*
Clomid*
HCG

Dihydrotestosterone Based
Primobolan
Masteron
Anavar
Proviron
Winstrol*
Anadrol*
Nandrolone (19-Nor) Based
Nandrolone
Trenbolone*

Peptide Hormones
Growth Hormone

Blood Glucose

Metformin
Slow and Fast Insulin*
Blood Pressure
ARBs PPAR y-agonist Telmisartan

Fat Loss Agents
Clenbuterol*
T3/T4*
Yohimbine HCl*
No asterisk = frequent use allowable; and have been or currently in human clinical use.
*Phase Dependent Drug to deploy conditionally due to necessity, goal and/or safety risk, have
been or currently in human clinical use.
**Not approved for Human Use, rare situation deployed